TREACE MEDICAL CONCEPTS, INC. (TMCI) › Operating Cash FlowTREACE MEDICAL CONCEPTS, INC. (TMCI) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$7.67M2020: -$4.49M2021: -$17.19M2022: -$30.65M2023: -$34.58M2024: -$37.17M2025: -$15.97M-$15.97M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$15.97M+57.0%2024-$37.17M-7.5%2023-$34.58M-12.8%2022-$30.65M-78.3%2021-$17.19M-282.6%2020-$4.49M+41.4%2019-$7.67M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share